How much funding has Prolaio raised?

Prolaio has disclosed $25.5M raised across 1 round.

Where is Prolaio headquartered?

Prolaio is headquartered in Scottsdale, US.

Prolaio

Scottsdale, US · Founded 2021 · Delaware corporation

Prolaio develops continuous, predictive heart data monitoring using high-density data capture and advanced analytics to support cardiovascular therapy development and patient care. It serves patients and drug developers in cardiology, aiming to replace episodic monitoring with real-world data and AI-based tools.

AI & Machine Learning Digital Health Healthtech Medical Devices

Founders & leadership

Konstantin PoukalovNamed on SEC filing

Jay EdelbergNamed on SEC filing

Tassos GianakakosinCo-founder

Reported raises · per SEC filings

Form D private placements

$25.5M disclosed across 1 round · 2023

▶$25.5MraisedJul 2023 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Konstantin PoukalovDirector
Jay EdelbergExecutive Officer, Director
Tassos GianakakosExecutive Officer, Director

Offering amount: $25.5M
Amount sold: $25.5M
First sale: Jul 2023
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Medscape26 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Prolaio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Prolaio do?: Prolaio develops continuous, predictive heart data monitoring using high-density data capture and advanced analytics to support cardiovascular therapy development and patient care. It serves patients and drug developers in cardiology, aiming to replace episodic monitoring with real-world data and AI-based tools.
How much funding has Prolaio raised?: Prolaio has disclosed $25.5M raised across 1 round.
Where is Prolaio headquartered?: Prolaio is headquartered in Scottsdale, US.